Disc Medicine, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $-10.4M | $3.3M |
| FY2020 | $14.0M | $-28.8M | $4.5M |
| FY2021 | — | $-64.2M | $88.0M |
| FY2022 | — | $176.6M | $194.6M |
| FY2023 | $0 | $345.1M | $360.4M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $-10.4M | $3.3M |
| FY2020 | $14.0M | $-28.8M | $4.5M |
| FY2021 | — | $-64.2M | $88.0M |
| FY2022 | — | $176.6M | $194.6M |
| FY2023 | $0 | $345.1M | $360.4M |